GlaxoSmithKline Pharmaceuticals Limited (BOM:500660)
India flag India · Delayed Price · Currency is INR
2,283.15
-16.95 (-0.74%)
At close: May 26, 2026

BOM:500660 Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
38,21737,49234,53732,51732,780
Revenue Growth (YoY)
1.93%8.56%6.21%-0.80%12.05%
Cost of Revenue
13,51114,13913,55213,04113,782
Gross Profit
24,70623,35420,98519,47618,998
Selling, General & Admin
6,0737,0187,3587,0627,397
Other Operating Expenses
5,5424,5244,5414,2723,931
Operating Expenses
12,27912,21012,59511,99212,010
Operating Income
12,42811,1438,3907,4846,988
Interest Expense
-27.3-13.14-17.99-18.12-19.96
Interest & Investment Income
-762.8729.28698.55711.53
Currency Exchange Gain (Loss)
--22.66--99.07-51.36
Other Non Operating Income (Expenses)
1,454---37
EBT Excluding Unusual Items
13,85411,8709,1018,0667,666
Merger & Restructuring Charges
---1,633-113.7-200.84
Gain (Loss) on Sale of Investments
-696.5487.76307.795.92
Gain (Loss) on Sale of Assets
--15.138.890.283.24
Asset Writedown
----2.61
Other Unusual Items
206.246.92196.87104.02314
Pretax Income
14,06012,5998,1628,3647,790
Income Tax Expense
3,7003,3232,2622,2883,983
Earnings From Continuing Operations
10,3609,2765,9006,0763,808
Earnings From Discontinued Operations
---30.4513,140
Net Income
10,3609,2765,9006,10716,947
Net Income to Common
10,3609,2765,9006,10716,947
Net Income Growth
11.69%57.23%-3.39%-63.97%373.19%
Shares Outstanding (Basic)
173169169169169
Shares Outstanding (Diluted)
173169169169169
Shares Change (YoY)
2.38%----
EPS (Basic)
59.7354.7634.8336.05100.04
EPS (Diluted)
59.7354.7634.8336.05100.04
EPS Growth
9.09%57.23%-3.39%-63.97%373.19%
Free Cash Flow
8,48012,6695,5084,4027,761
Free Cash Flow Per Share
48.8974.7832.5125.9845.81
Dividend Per Share
45.00042.00032.00032.00030.000
Dividend Growth
7.14%31.25%-6.67%-
Gross Margin
64.65%62.29%60.76%59.89%57.96%
Operating Margin
32.52%29.72%24.29%23.02%21.32%
Profit Margin
27.11%24.74%17.08%18.78%51.70%
Free Cash Flow Margin
22.19%33.79%15.95%13.54%23.68%
EBITDA
13,09211,5278,8057,8847,428
EBITDA Margin
34.26%30.75%25.50%24.25%22.66%
D&A For EBITDA
664.4383.57415.36399.67439.6
EBIT
12,42811,1438,3907,4846,988
EBIT Margin
32.52%29.72%24.29%23.02%21.32%
Effective Tax Rate
26.32%26.38%27.72%27.35%51.12%
Revenue as Reported
39,67038,95135,76333,52433,538
Advertising Expenses
-1,2021,0941,0911,277
Source: S&P Global Market Intelligence. Standard template. Financial Sources.